chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache started soon after getting vaccine which was the only vaccine given that day (1st HPV). Headache worsened throughout evening. Went to bed, and awoke at 12:30 AM still with severe headache, went into bathroom and lost consiousness. Family entered quickly and found him seizing. Called 911, taken to ER. CXR done,no xray of head, heartbeat steady. Rx for nausea and pain. Observed for a couple of hours, very sleepy, and sent home. Now fine but will not get more HPV vaccines.
Pt devel flu-like resp sx 11 days p/being administered Influenza vax; This necessitated a MD visit;
Following vaccines the infant was reported to be "lethargic" - sleeping and "crying hysterically" when aroused. Refused  PO x 24 hours. Sent to ER.
At 2 of 1/22/21 Administration of the 1st dose I started with pain and weakness. February 9 intense pain in both shoulders but stronger on the right one. Appointment with a rheumatologist for sever pain, ordered labs and started on prednisone 15 mg Am and 15 mg Pm. Also, Plaquenil 400 mg daily
Onset tenderness, induration and heat 3 days after vaccine (Td), has remained unchanged since then.
Pt recv vax on 2/25/99; 2 hr post vax pt exp rt arm pain/weak, fainted, urinary incontinence & stiffening
i amsick; is it possible to be allergic; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, 1 day after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness and allergic reaction. On an unknown date, the outcome of the sickness and allergic reaction were unknown.   It was unknown if the reporter considered the sickness and allergic reaction to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information was provided as follows: The age at vaccination was not reported. The patient experienced allergic reactions and sickness after receiving a flu shot. No further information was provided.
I experienced a metallic taste in my mouth a few minutes after receiving the vaccine. I mentioned it to the pharmacist and was asked to report it to the CDC. It lasted a few minutes, with no other symptoms occurring.
Narrative: pt reported moderate dizziness after covid 19 vaccine (Moderna); stated that by next day dizziness went from moderate to mild but continued for a month; also had trouble concentrating on tasks for a month.
Feeling cold; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling cold), HEADACHE (Headache) and PYREXIA (Fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No medical history provided. No concomitant medication information provided.     On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced FEELING COLD (Feeling cold), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with BACILLUS POLYFERMENTICUS (SALVADOL M) at a dose of 250 mg. At the time of the report, FEELING COLD (Feeling cold), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter.
2nd Vaccine - 48-72 hours of general flu like malaise,  fatigue, weakness, dizziness, headache, body fever and some chills.  Foggy brain and dehydrated.   Slept for 2 days during bout of 2nd Moderna vaccination and had some relief on 3rd day but brain fog for almost a week.   Booster vaccine - 24 hours of sleep, dehydrated, some slight fever, dizziness, next 24 more awake time but fatigued and weak.   Related flu like symptoms   Slowly returning to normal with some fatigue
Throwing up, violently; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via an unspecified route of administration in right arm on 12Jan2021 11:30 AM at for COVID-19 immunization. Medical history included breast cancer, heart valve problem, asthma, and allergies. The patient's concomitant medications were not reported. The patient experienced throwing up, violently on 12Jan2021 11:30 AM. Patient dose not have COVID prior vaccination. Patient was not tested for COVID post vaccination. No treatment was received for the adverse event. The outcome of the event was recovering.
1.At time of vaccination-Felt flush, dizzy, mild breathing difficulty- resolved with 1 OTC dose of Benadryl 2. 2 days after the vaccination I developed a high fever of 103, chills, headache, runny nose- lasted for 5 days with fever gradually lowering until normal 3. January 1 I developed a rash on my arm around the site of the injection- raised rash, itchy, hot to the touch. Rash began growing in size, with increased symptoms of shoulder pain/aching, headache, low grade fever-100. I took 3 Benadryl and put hydrocortizone cream on it,. By this morning it decreased in puffiness/swelling and redness, but has spread to cover my entire upper left arm and is still like that.
Inj 5/30-5 PM. 1st appearance of red splotches 6/1 (felt itchy 5/31); arms, neck, chest, foot; more outbreak, same areas as day progressed-nothing at injection site (no soreness, red circle, warmth), no fever, no chest pain.
Soreness at injection site; Hardness at injection site; Sneezing; Coughing; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE INDURATION (Hardness at injection site), SNEEZING (Sneezing), COUGH (Coughing) and RHINORRHOEA (Runny nose) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE INDURATION (Hardness at injection site), SNEEZING (Sneezing), COUGH (Coughing) and RHINORRHOEA (Runny nose). On 07-Jul-2021, VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE INDURATION (Hardness at injection site) had resolved. At the time of the report, SNEEZING (Sneezing), COUGH (Coughing) and RHINORRHOEA (Runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. No concomitant medications were reported.
Headache and body aches for 3-4 days fatigue and weakness for 7-10 days diarrhea for 3 weeks
Had chills, fever of 102. Had Tylenol.  Next day fever of 101 with malaise, body ache. Had insomnia, hyperactivity and jittery x 3 days.
Vaccinated 4 Dec 11. Discovered 19 Dec 11. She was 7 wks pregnant.
Client received second dose of COVID19 on Jan 2 2021.  she had no side effects. She came into contact with 3 COVID positive people.  She reported some mild nasal congestion on Tuesday 3/9/2021.  She tested positive and was retested on 3/12 again positive. She has had no other symptoms and is not experiencing any symptoms as of 3/13/2021
Apparent Shoulder Injury Related to Vaccine Administration (SIRVA). Sharp Pain at certain rotations and general soreness currently at 17 days from injection. The injection was particularly painful
Diarrhea 3 mo post vaccine. Diarrhea started at end of April the  3rd week, 10-15 times per day and went to ED, stool cultures and blood work and all WNL, lost 27 lbs through June, slowed down in past 2 weeks. Vaccines April 7 and 29. Not continuing to lose weight at this point. Diarrhea twice yesterday, immodium does not work. Has GI appt in October and colonoscopy and endoscopy then.
Sunday, January 10 2021 around 1900. Suffered from chest pain. EKG showed STEMI. Chest x-ray showed 20% pneumothorax. Treated with nonrebreather 15L for several hours. Follow-up EKG shows retaining right bundle branch block.
got some rash in my legs just like the chicken pox; This case was reported by a consumer via interactive digital media and described the occurrence of varicella-like rash in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced varicella-like rash. On an unknown date, the outcome of the varicella-like rash was unknown.   It was unknown if the reporter considered the varicella-like rash to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  Patient received the 2nd dose of shingles vaccine and got some rash on legs just like the chicken pox. Patient mentioned that it was still better than having shingles. It was stated that patient had a cousin who had it twice and cousin said it was the most painful thing in the world. Patient paid insurance for himself and for his wife.
Patient received casirivimab instead of intended COVID vaccine.  48-hr follow up didn't identify AEs. Patient received COVID vaccine on December 31.
I collapse, I didn't lose consciousness I don't know how I ended up on the floor. after 45 minutes I was very nauseous, i was sweating profusely and I was so weak that I couldn't take off my clothes. I didn't throw up i was so hot and I've never felt this way. It went through my mind that I could be going thru a heart attack.  I didn't have shortness of breath or chest tightness, no pressure and nothing of the sort. I didn't experience any sickness after the 2 hours of sleep. I did a virtual visit on Monday on the 22 of November and I will be seeing Cardiologist and a Neurologist.
Patient came in the day following the vaccinations complaining of swelling, aches , uspet stomach, head ache, ear ache, sweeting thoughout the night. Called patient 9/29/19 and she is feeling much better
Raised bumps, head, back, shoulders, and neck. Itchy, 3/6/03.
This spontaneous report was received from a physician via company representatives and from a support services director, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. There were no concomitant medications provided. On 30-DEC-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB "PFS 6x1 10mg/1ml w/o SftySyr" (dose, dose number, route and anatomical location were not reported) lot # J010164 and expiration date 03-FEB-2016. On an unspecified date, the RECOMBIVAX HB had 2 temperatures excursion of 6660 and 8748 hours. The lowest recorded temperature was 20 degrees Fahrenheit (-6.666666667 degrees Celsius). No adverse effects reported. No product quality complaint was involved. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "Refrigerator (R)". This is one of several reports received from the same reporter. Additional information has been requested.
it made him Ill and unable to cope withe a condition he didn't know; Initial information received on 03-Oct-2021 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp health care professional   This case involves male patient of an unknown age who was ill and unable to cope with a condition he didn't know (illness) and died, after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious ill and unable to cope with a condition he didn't know (illness) (unknown latency) following the administration of INFLUENZA VACCINE. This event was leading to death.  There were no lab data/results available.  It was unknown if the patient experienced any additional symptoms/events  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was fatal for the reported event.  It is unknown if an autopsy was done. The cause of death was reported as Illness.  Information on the batch number to be requested.; Sender's Comments: This poorly documented social media case concerns a male patient (age unknown) who had illness and died, after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. It was unknown if an autopsy was done. Further information regarding patient's past medical condition, previous vaccination tolerance and other laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of a suspect vaccine cannot be assessed.; Reported Cause(s) of Death: it made him Ill and unable to cope withe a condition he didn't know he had leading to his death
Redness & swelling immediately, progressing  down left arm daily for 5 days to just above the elbow.  It was painful and felt like a lump when touched. It was also very hot to the touch.  Symptoms went away after 6 days. Then it began to itch.
seizures; tremors; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the parent.  A 17-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 2021, for COVID-19 immunization.  The following information was reported: SEIZURE (medically significant), outcome "unknown", described as "seizures"; TREMOR (non-serious), outcome "unknown", described as "tremors". It was reported that patient was now 17-years and got both the Pfizer shot last year. About 2 months after the 2nd shot she started to have tremors and seizures. It was concerned that before the shots none of these happened and was requested to advise.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Approx 1-2 weeks after injection, developed bursitis in Left shoulder.  At time of injection pt had no pain, swelling, bruising or reddness.  Pain continues at this time.
Constant sleeping and crying for first week. Screaming in the middle of the night ever since. Had to take him to the emergency room on March 22, 2017 because he woke early in the morning screaming and could not move. Some nights, while sleeping, he is flat on his back, straight and shaking/jolting. Possible seizures. Always wakes screaming. Since the most recent incidence on 7/5/2017, he has been walking into walls and randomly collapsing.
Myalgia & NauseaVomiting Narrative: fatigue, GI symptoms, pain at injections site, unable to work due to incapacitation on 1/26/2021 from 1300-1530 & 1/27/2021 0700-1530
received Engerix-B 4th dose; third dose 7/14/2020, first and second Oct 2002 and Dic 2002 respectively; third dose 7/14/2020, first and second Oct 2002 and Dic 2002 respectively; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 17-year-old female patient who received HBV (Engerix B) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix-B (received 1st dose in October 2002).   On 30th June 2022, the patient received the 4th dose of Engerix B. On 14th July 2020, the patient received the 3rd dose of Engerix B. In December 2002, the patient received the 2nd dose of Engerix B. In December 2002, unknown after receiving Engerix B, the patient experienced drug dose administration interval too long. On 14th July 2020, the patient experienced drug dose administration interval too long. On 30th June 2022, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered, drug dose administration interval too long and drug dose administration interval too long were unknown.   Additional Information: GSK receipt date: 01-Aug-2022 Reporter's comment: The nurse reported that they had two patients received Engerix-B extra dose by error. The reporter consented to follow-up via email. The case is for 2 of 2 linked patients, reported by same reporter. Additional supportive information: The patient received the 2nd and 3rd dose of Engerix-B later than the recommended interval, which led to lengthening of vaccine schedule. The patient also received 4th dose of Engerix-B, which led to extra dose administered. As the patient received an extra dose of Engerix-B and it was clear that the dose was given by error and intention behind the dose giving was unknown therefore extra dose administered event was coded.; Sender's Comments:  US-GSK-US2022113816:Same reporter
Lymphadenopathy near left side of clavicle, near injection site; This is a Spontaneous report from a contactable Consumer (patient). A 22-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on left arm on 09Jan2021 at 13:00 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient experienced lymphadenopathy near left side of clavicle, near injection site on 10Jan2021 at 13:00. The patient did not receive treatment for the event. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the event was not recovered.  Information about Lot/batch number has been requested.
Information has been received from a registered nurse concerning a 16 year old female with no past medical and NKDA who on 10/31/01 was vaccinated with varicella virus vaccine live (site unknown) SC. There was no concomitant medication. It was reported that "two weeks later" the pt developed a red rash, "dots appearance", over the entire body. It was noted that no vesicles were present. There was no specific treatment, comfort measures only. Follow-up described the event as a varicella-form eruption", which the reporting physician stated as "not a big deal"  and did not considered the experience an adverse reaction.
approx 24hr p/vax mom states pt had elevated fever & devel a rash on chest;stated had been giving APAP but it only lowered temp sl;also gave DPH per MD instruction;
8/26 Patient returned to pharmacy 48 hours after receiving vaccine and and reported severe arm pain, knot at injection site, and slight redness. The patient was assessed and denied having any of the following: hives, difficulty breathing, fever, tingling in the arms or feet. After physical assessment it was determined to be a severe injection site reaction and the patient was advised to take ibuprofen and use ice on and off. The patient was also instructed to seek medical attention if she developed a fever, difficulty breathing, the redness became more severe or if she had any reason to suspect it was getting worse. 8/27 Patient was contacted the following day and told the pharmacy she was feeling better. 8/28 Patient came in to pharmacy and there was bruising on her arm, but stated it does feel better than it previously did.
Initial report was received 03 October 2008 from a health care professional.  An adult female patient (age not reported) had received an intramuscular left deltoid injection of ADACEL, lot number C2995BA and an injection of PNEUMOVAX, lot number 1679U (manufacturer Merck, route and site not reported) on an unspecified date and four days later, developed pain and tenderness, swelling, increased redness, warmth, and an erythematic lesion (with no blisters) at the left deltoid injection site.  The patient had no concurrent illness at the time of vaccination and had not received any other vaccines within four weeks of ADACEL and PNEUMOVAX.  The patient was evaluated by her physician and had been diagnosed with Cellulitis.  Corrective treatments consisted of a warm compress application for two to three days, Motrin prn, and Keflex for seven to ten days.  The patient's recovery status was unknown at the time of the report.  This event involved a cluster of two patients in which the other patient had been captured in case number 2008-03022.
It was extremely painful when I received the vaccine and I immediately felt my fingers tingling. In about 10 min I felt very hot in my face, back and felt like I was going to pass out. My heart was racing, it was about 130. My BP initially was 139 and then 160 after that. I never passed out but I felt those waves with a tingling to my face and my neck as I was going to pass out and I started shaking and my heart was racing and my BP was up and it lasted about 45 min before it started going down.  They gave me some Ibuprofen at the Employee health and they kept observing me and it started getting better after 45 min. I still felt the waves of feeling flush and hot and cold and very fatigued.
The morning of 06/11/2022 I began to experience aches and chills but no fever. I had that reaction to all previous vaccine doses but I continued to feel tired through Monday. Monday night 06/13/22 I started getting alarms from my apple watch that my resting heart rate was in the 130's and I felt uncomfortable in the sense that my heart was beating quickly. That continued overnight and then I set up the EKG function on apple watch and was notified I was in afib and pulse rate was 130-140. After talking to my Doctor I went to the ER and was found to be in afib from an Echocardiogram and I received medicine to slow it down and IV medicine to try to slow it down and eventually I had to be admitted because my heart rate wouldn't get under control. I ended up going back into regular rhythm after treatment and the echocardiogram was normal and the blood work was normal including a thyroid function. They couldn't find anything specific that caused it based on the testing they did. I went home the next day after 24 hours and they changed my medication and metoprolol was stopped and I was put on blood thinners. I saw cardiologist for a follow-up on Friday 06/24/22 and I am now wearing a 2 week monitor to see what my heart is doing and I was also in normal rhythm when I seen cardiology on Friday.
not getting high enough IG and requiring boosting as they get sick; This is a spontaneous report received from a contactable reporter(s) (Other HCP)\.  A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "not getting high enough IG and requiring boosting as they get sick".  Additional information: Some kids [5 over the last few years] not getting high enough IG and requiring boosting as they get sick.  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300092588 same drug and event with different patient.;